Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5180929
Max Phase: Preclinical
Molecular Formula: C26H19F3N2O2S
Molecular Weight: 480.51
Associated Items:
ID: ALA5180929
Max Phase: Preclinical
Molecular Formula: C26H19F3N2O2S
Molecular Weight: 480.51
Associated Items:
Canonical SMILES: Cc1c(-c2cccc(C(F)(F)F)c2)sc2[nH]c(=O)n([C@H](C)c3cccc4ccccc34)c(=O)c12
Standard InChI: InChI=1S/C26H19F3N2O2S/c1-14-21-23(34-22(14)17-9-5-10-18(13-17)26(27,28)29)30-25(33)31(24(21)32)15(2)19-12-6-8-16-7-3-4-11-20(16)19/h3-13,15H,1-2H3,(H,30,33)/t15-/m1/s1
Standard InChI Key: XKCIYWJZAMFYTL-OAHLLOKOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 480.51 | Molecular Weight (Monoisotopic): 480.1119 | AlogP: 6.51 | #Rotatable Bonds: 3 |
Polar Surface Area: 54.86 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.10 | CX Basic pKa: | CX LogP: 7.73 | CX LogD: 7.73 |
Aromatic Rings: 5 | Heavy Atoms: 34 | QED Weighted: 0.32 | Np Likeness Score: -1.11 |
1. Xiao Z, Osipyan A, Song S, Chen D, Schut RA, van Merkerk R, van der Wouden PE, Cool RH, Quax WJ, Melgert BN, Poelarends GJ, Dekker FJ.. (2022) Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione Derivative Inhibits d-Dopachrome Tautomerase Activity and Suppresses the Proliferation of Non-Small Cell Lung Cancer Cells., 65 (3.0): [PMID:35041425] [10.1021/acs.jmedchem.1c01598] |
Source(1):